Internet Pioneer In...
Health Care: Drugs
Labopharm Inc. (DDSS: OTC)
$0.28 0.01 | 3.34%
10/12/11 - 03:53 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| DDSS | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -74.55 | -84.09 | -91.57 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 26.20 | 0.55 | 0.15 |
| Net Income | -0.21 | 0.00 | |
| EPS | -0.34 | 0.00 |
Earnings for DDSS:
| EBITDA | -21.00 |
| REVENUE | 29.57M |
Average Earnings Estimates
| Qtr (06/11) | Qtr (09/11) | FY (12/11) | FY (12/12) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $-0.24 | $-0.06 |
| Number of Analysts | 0 | 0 | 2 | 2 |
| High Estimate | $n.a. | $n.a. | $-0.20 | $0.05 |
| Low Estimate | $n.a. | $n.a. | $-0.27 | $-0.17 |
| Prior Year | $-0.08 | $-0.10 | $-0.42 | $-0.24 |
| Growth Rate (Year over Year) | n.a.% | n.a.% | 44.05% | 74.47% |
Portfolios with DDSS
- Portfolio NameUser Type
- Userbmansfield Portfolio 1
- Userannavua2000@yahoo.com Portf...
- UserSUPRATRADE SMALL CAP TEST-0...
- Userbonbon13850 Portfolio 1
- Userjcstocks13 Portfolio 1
- UserSUPRATRADE VERY BAD PORTFOLIO
- Userbettz777 Portfolio 1
- Userfed3 52 week low on 6-13-2007
- Usermassy shok Portfolio 1
- Userkghosh10 Portfolio 1
Latest DDSS Headlines from TheStreet
- Biotech Stock Mailbag: Vical 01.21.11 | 07:01 am
- Biotech Stock Mailbag: Exact Sciences 10.15.10 | 07:10 am
- Biotech Stock Mailbag: Immunomedics 05.14.10 | 07:05 am
- Biotech Stock Mailbag: Labopharm 04.23.10 | 07:04 am
- Labopharm, China Direct: Early Volume Plays 02.12.10 | 07:02 am
- Somaxon, Borders: Midday Volume Plays 02.03.10 | 01:02 pm
- Home Diagnostics, GT Solar: Early Volume Plays 02.03.10 | 07:02 am
- Biotech Calendar: Key Dates for February 02.02.10 | 06:02 am
- Labopharm, Borders: Midday Volume Plays 01.26.10 | 12:01 pm
- Midday Movers: Pump Up the Volume 10.08.09 | 02:10 pm
Press Releases for DDSS
- LABOPHARM ANNOUNCES REDUCTION OF ANGELINI LABOPHARM'S OLEPTRO⢠SALES FORCE - PR Newswire 06.23.11 | 05:06 pm
- LABOPHARM ANNOUNCES INTENTION TO DELIST FROM NASDAQ - PR Newswire 06.21.11 | 05:06 pm
- LABOPHARM REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2011 - PR Newswire 05.04.11 | 07:05 am
- LABOPHARM TO HOST CONFERENCE CALL WEDNESDAY, MAY 4, 2011 AT 8:30 A.M. (ET) - PR Newswire 04.29.11 | 12:04 pm
- LABOPHARM PROVIDES UPDATE ON STRATEGIC REVIEW PROCESS - PR Newswire 04.29.11 | 07:04 am
- LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES - PR Newswire 04.01.11 | 05:04 pm
- LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO - PR Newswire 03.22.11 | 09:03 am
- LABOPHARM ANNOUNCES APPOINTMENT OF NEW PRESIDENT & CEO - PR Newswire 03.14.11 | 07:03 am
- LABOPHARM REPORTS PROGRESS AND FINANCIAL RESULTS FOR FOURTH QUARTER 2010 - PR Newswire 02.24.11 | 07:02 am
Partner Headlines for DDSS
- Labopharm Receives Health Canada Approval for OLEPTRO - Benzinga 01.20.11 | 09:01 am
- FDA, Clinical Trial Binary Events: Amarin, Amicus, Labopharm - Seeking Alpha 08.08.10 | 08:08 am
- Medication With Staying Power: A Look at Some Manufacturers - Seeking Alpha 05.09.10 | 11:05 am
